ロード中...
Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications
Malignant pleural mesothelioma (MPM) tumors are remarkably aggressive and most patients only survive for 5–12 months; irrespective of stage; after primary symptoms appear. Compounding matters is that MPM remains unresponsive to conventional standards of care; including radiation and chemotherapy. Cu...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2018-01-01
|
| シリーズ: | International Journal of Molecular Sciences |
| 主題: | |
| オンライン･アクセス: | http://www.mdpi.com/1422-0067/19/1/238 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|